Literature DB >> 6281325

Small cell lung carcinoma in the elderly.

G H Clamon, M W Audeh, S Pinnick.   

Abstract

Twenty-four patients over the age of 70 with small cell cancer of the lung were studied retrospectively. Ninety-two per cent of these patients had other concurrent medical disorders; 58 per cent had cardiac disease and 25 per cent had a second malignancy. The median survival of 20 treated patients was ten months, and the one-year survival was 30 per cent. Such elderly patients with multiple medical problems can benefit from combination chemotherapy.

Entities:  

Mesh:

Year:  1982        PMID: 6281325     DOI: 10.1111/j.1532-5415.1982.tb05616.x

Source DB:  PubMed          Journal:  J Am Geriatr Soc        ISSN: 0002-8614            Impact factor:   5.562


  3 in total

Review 1.  Minimising the side effects of cancer chemotherapy in senior patients.

Authors:  T Kinzel; V Feleppa
Journal:  Drugs Aging       Date:  1992 Mar-Apr       Impact factor: 3.923

Review 2.  Treatment and outcomes for elderly patients with small cell lung cancer.

Authors:  R J Stephens; D H Johnson
Journal:  Drugs Aging       Date:  2000-09       Impact factor: 3.923

Review 3.  The aged patient with lung cancer. Management recommendations.

Authors:  V Zagonel; U Tirelli; D Serraino; G Lo Re; M C Merola; M Mascarin; M G Trovò; A Carbone; S Monfardini
Journal:  Drugs Aging       Date:  1994-01       Impact factor: 3.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.